
25/08/2025
A revolutionary “liquid biopsy” blood test can now detect 14 different types of cancer at their earliest stages with more than 95% accuracy. By analyzing DNA methylation patterns tiny chemical changes that indicate cancer the test identifies deadly diseases like pancreatic, liver, ovarian, and even rare esophageal cancer long before symptoms appear. Requiring only a few drops of blood, it can be done during a routine checkup, making early detection faster and more accessible. If widely adopted, this breakthrough could transform global healthcare, enabling large-scale cancer screening and potentially saving millions of lives through earlier treatment and intervention.